Apr 28, 2026BoardMeeting
BoardInstitutional Biosafety Committee Meeting Minutes
The committee conducted a continuing review of a Phase 2 study for a GPRC5D-directed CAR T cell therapy. Key discussion topics included the reaffirmation of BSL-2 containment requirements, the oversight period, and a review of facility practices regarding biohazardous waste storage and study agent preparation. The committee formally approved both the research protocol and the site requirements after verifying documentation and site safety procedures.